KHtech(SH:603052) Xuan Gu Bao·2026-01-07 12:04Fundraising - Amperon plans to raise no more than 544 million yuan for projects including pressure sensor capacity expansion, ceramic capacitive pressure sensor production line upgrades, force sensor production line construction, MEMS sensor chip R&D and industrialization, as well as to supplement working capital [1] Shareholding Changes - Longjin Technology's shareholder Zhejiang Jingjiantou intends to transfer 4.6 million shares, accounting for 5% [2] - Baomo Co., Ltd.'s actual controller is planning matters related to the change of company control [3] - Anfu Technology's directors and senior management plan to increase their holdings by 11.9 million to 13.4 million yuan [4] - Xiangyang Bearing's controlling shareholder Sanhuan Group is transferring 599% of its shares to Changjiang Industrial Group without compensation [5] - Meibang Fashion's controlling shareholder Huafu Investment intends to transfer 7.90% of the company's shares to Taizhou Xinmeng [6] External Investments and Daily Operations - Kechuan Technology's wholly-owned subsidiary has completed the construction of optical module capacity, and silicon optical chips have completed their first tape-out, but no revenue has been generated yet [7] - Guangqi Technology has signed batch production contracts for metamaterials products totaling 264 million yuan with four clients [8] - Heng Rui Medicine's innovative drug Ruilafup α injection has been approved for market launch, with no similar products approved domestically or internationally [9] - Chengdi Xiangjiang has decided not to proceed with the construction of the data center computing power infrastructure project, which is expected to reduce revenue by approximately 1.092 billion yuan [9] Performance Changes - Zhongke Lanyun expects a net profit of 1.4 billion to 1.43 billion yuan for 2025, an increase of 366.51% to 376.51% year-on-year, with significant growth attributed to fair value changes from investments in Moer Thread and Muxi Co., Ltd. [10] - Kangchen Pharmaceutical anticipates a net profit of 145 million to 175 million yuan for 2025, representing a year-on-year increase of 243% to 315%, with no impact from goodwill impairment provisions [10] - Beifang Navigation expects a net profit of 110 million to 140 million yuan for 2025, a year-on-year growth of 86.32% to 137.14%, driven by increased product deliveries and sales revenue [10] - Chuanjinno expects a net profit of 430 million to 480 million yuan for 2025, reflecting a year-on-year increase of 144.24% to 172.64% [11]